Suresh S. Ramalingam, MD

Professor, Hematology & Medical Oncology

Emory University School of Medicine

Deputy Director

Winship Cancer Institute of Emory University

Assistant Dean for Cancer Research

Emory University School of Medicine

Director, Division of Medical Oncology, Department of Hematology & Medical Oncology

Emory University School of Medicine

Office: Winship Cancer Institute of Emory University

Phone: (404) 778-5378

Fax: (404) 778-5520

Email: ssramal@emory.edu

Biography

Dr. Suresh Ramalingam received his medical degree at Kilpauk Medical College, Madras, India. He completed his residency in internal medicine at Wayne State University, Detroit, MI, where he also served as a Chief Medical Resident. He then completed a fellowship in hematology and medical oncology at the University of Pittsburgh Medical Center, Pittsburgh, PA. Board certified in internal medicine and medical oncology, Dr. Ramalingam is nationally recognized as an investigator and a physician in the area of small cell and non-small cell lung cancer.

In 2016, Dr. Ramalingam was named Deputy Director of Winship Cancer Institue of Emory University where he leads the integration of the research, clinical, and educational components for the institution.

Dr. Ramalingam is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. He is also an active member of American Society of Clinical Oncology, the American Association for Cancer Research, and the International Association of Lung Cancer Study. Dr. Ramalingam plays a leadership role in the ECOG-ACRIN Cancer Research Group as the Chair of the Thoracic Malignancies Committee. He also serves on the editorial board of leading cancer journals such as Journal of Clinical Oncology, Cancer, Clinical Lung Cancer and Cancer.

Dr. Ramalingam is the recipient of several awards, including the ‘James Eckman Award for Excellence in Teaching’, Department of Hematology and Medical Oncology, Emory University, and the Distinguished Cancer Scholar Award, Georgia Cancer Coalition. In addition, he is also a recipient of the ‘ASCO Career Development Award’ (2006-09). Dr. Ramalingam serves on several international, national and Institutional Committees. He is a recipient of peer-reviewed grants funded by the NCI.

Full Clinical Bio >>

Research

Dr. Ramalingam's research interests include development of novel anti-cancer agents and evaluation of methods to individualize therapies to patients. He has conducted several early phase clinical trials with molecularly targeted agents in the treatment of small cell and non-small cell lung cancer. He is currently involved in the development of agents that inhibit the mTOR, HDAC, DNA repair and EGFR pathways.

Publications

Dr. Ramalingam's research work has been published in leading journals such as the Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer.

Clinical Trials

View clinical trials at Winship Cancer Institute